These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 10189538
1. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538 [Abstract] [Full Text] [Related]
2. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, Watanabe H, Fujikawa R, Okubo M, Kohno N. J Diabetes Complications; 2005 Apr; 19(1):47-53. PubMed ID: 15642490 [Abstract] [Full Text] [Related]
3. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Arch Intern Med; 1998 Feb 09; 158(3):289-92. PubMed ID: 9472210 [Abstract] [Full Text] [Related]
4. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. Saltzman CL, Rashid R, Hayes A, Fellner C, Fitzpatrick D, Klapach A, Frantz R, Hillis SL. J Bone Joint Surg Am; 2004 Apr 09; 86(4):717-23. PubMed ID: 15069135 [Abstract] [Full Text] [Related]
5. Sensory thresholds of normal human feet. Jeng C, Michelson J, Mizel M. Foot Ankle Int; 2000 Jun 09; 21(6):501-4. PubMed ID: 10884110 [Abstract] [Full Text] [Related]
6. Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Sosenko JM, Sparling YH, Hu D, Welty T, Howard BV, Lee E, Robbins DC. Diabetes Care; 1999 Oct 09; 22(10):1715-21. PubMed ID: 10526741 [Abstract] [Full Text] [Related]
7. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Miranda-Palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJ. Diabetes Res Clin Pract; 2005 Oct 09; 70(1):8-12. PubMed ID: 16126117 [Abstract] [Full Text] [Related]
8. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. Feng Y, Schlösser FJ, Sumpio BE. J Vasc Surg; 2009 Sep 09; 50(3):675-82, 682.e1. PubMed ID: 19595541 [Abstract] [Full Text] [Related]
9. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening. Dimitrakoudis D, Bril V. Neurology; 2002 Aug 27; 59(4):611-3. PubMed ID: 12196660 [Abstract] [Full Text] [Related]
12. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study. Adams OP, Herbert JR, Howitt C, Unwin N. Diabet Med; 2019 Dec 27; 36(12):1629-1636. PubMed ID: 31094005 [Abstract] [Full Text] [Related]
13. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. Oyer DS, Saxon D, Shah A. Endocr Pract; 2007 Dec 27; 13(1):5-10. PubMed ID: 17360294 [Abstract] [Full Text] [Related]
17. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study". Jurado J, Ybarra J, Pou JM. Nurs Clin North Am; 2007 Mar 27; 42(1):59-66. PubMed ID: 17270590 [Abstract] [Full Text] [Related]
19. Use of the Semmes-Weinstein 5.07/10 gram monofilament: the long and the short of it. McGill M, Molyneaux L, Yue DK. Diabet Med; 1998 Jul 27; 15(7):615-7. PubMed ID: 9686703 [Abstract] [Full Text] [Related]